SCHEMBL22492467

SCHEMBL22492467

[2H]C([2H])([2H])N=C(N)NCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL580048 0.85
Hydrochloric Acid SCHEMBL11809895 0.83 CTH (0.41)
Ammonia Solution, Strong SCHEMBL4743453 0.83 CTH (0.41)
Hydrochloric Acid SCHEMBL11809897 0.83 CTH (0.41)
SCHEMBL24021305 0.73
SCHEMBL7859372 0.73
SCHEMBL21461380 0.73
SCHEMBL18541270 0.73
SCHEMBL17234241 0.73
SCHEMBL28619525 0.72 NOS1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717453-A2 CREATINE PRODRUGS, COMPOSITIONS AND METHODS OF USE THEREOF Ultragenyx Pharmaceutical Inc. (US) 2020-10-07 EP disclosed